Tradename
Spasmopyralgin-M
Generic Name
Category
Gastrointestinal System
Form
Various
Composition
Tablets
Camylofin...................25 mg
Analgin.....................255 mg
Drops (each 1 ml contains)
Camylofin....................25 mg
Analgin......................255 mg
2 and 5 ml Ampoules (each 1 ml contains)
Camylofin.....................10 mg
Analgin.......................258 mg
Suppositories
For adults:
Camylofin.....................40 mg
Analgin.......................500 mg
For children:
Camylofin.....................20 mg
Analgin.......................250 mg
Description
Antispasmodic, analgesic, and antipyretic.
Properties/Actions
Spasmopyralgin-M (different forms) provides a powerful antispasmodic, analgesic and antipyretic effects, produced by its contents of the efficient antispasmodic Camylofin, and the potent analgesic/antipyretic Analgin.
Spasmopyralgin-M removes spasm and pain effectively.
Indications
Spasmopyralgin-M is indicated in:
  • Biliary, renal and intestinal colics.
  • Dysmenorrhoea and cervical spasm.
  • As antipyretic.
  • Pains due to pancreatitis.
Contraindications
Spasmopyralgin-M is contraindicated in:
  • Hypersensitivity to any of the components.
  • Blood diseases, rapid cardiac arrhythmia.
  • Narrow angle glaucoma.
  • Prostatic hypertrophy and obstructive bowel diseases.
Drug Interactions
The following interactions have been noted:
  • With camylofin, addivtive anticholinergic effects may occur when given concomitantly with anticholinergics, antihistaminics, tricyclic antidepressants or quinidine.
  • With analgin, additive haematological disturbances may occur when given concomitantly with chloramphenicol, sulphonamides or other bone marrow depressants.
Side Effects/Adverse Effects
The following side effects have been reported:
  • Hypersensitivity reactions in susceptible patients.
  • Occasionally dry mouth, flushing, blurred vision, tachycardia, difficulty in micturition.
  • Haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency.
  • With prolonged therapy, analgin-induced blood dyscriasis may occur which is reversible on discontinuation of therapy.
  • Hypotension may occur with injection when gvein IV rapidly.
Pregnancy & Lactation
Contraindicated in pregnant and nursing mothers.
Dosage & Administration
1. Tablets:
  • Adults: 1-2 tablets, one to three times daily.
  • Children (10-12 years): 1 tablet, one to three times daily.
2. Injectable forms:
Adults:
  • In severe attacks, 1 injection of 5 ml IV, to be repeated if necessary.
  • In less severe attacks, 2-5 ml IM.
Children:
  • Doses are to be given as directed by the physician.
  • Given from 1-3 times daily.
3. Drops:
Children:
  • 6 months to 3 years: 5-10 drops.
  • 3 to 6 years: 12-15 drops.
  • 6 to 12 years: 17-20 drops.
4. Suppositories:
Adults:
  • 1 adult suppository, 2-3 times daily.
Children: (use children suppositories)
  • Infants from 6 months: 1/2 suppository, 2-3 times daily.
  • Children up to 5 years: 1 suppository, 1-2 times daily.
  • Over 5 years: 1 suppository, 2-3 times daily.
Overdosage
Warnings
To be used with caution in patients with asthma or other allergic disorders.
Patients allergic to other pyrazoline derivatives may also be allergic to Analgin.
If administered intravenously, inject slowly into the vein over one minute. If injected rapidly, there is a possibility of sudden decrease in blood pressure and subsequent shock.
Notes
Storage
Tablets, drops, ampoules: Store at room temperature, away from light and humidity.
Suppositories: Store in a cool place.
Packaging
Tablets: Strips of 10 tablets.
Drops: Bottles of 15 ml with dropper.
Ampoules: boxes of 5 ampoules of 2 ml or 5 ml.
Suppositories: Boxes of 5 suppositories for adults or children.
Manufacturer
Kahira Pharma and Chemical Ind. Co.
Price
Date Added/Updated
18th February 2010 4:26 pm

Miscellaneous

Share This!

Respected Sites

drugs.com

rxlist.com

rxwiki.com

Need Help?

on-call support